Cornerstone Capital Management Holdings’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,010	Closed	-$73K	–	1512
2015 Q1	$73K	Hold	5,010	–	–	﹤0.01%	1294
2014 Q4	$42K	Hold	5,010	–	–	﹤0.01%	1214
2014 Q3	$56K	Hold	5,010	–	–	﹤0.01%	1210
2014 Q2	$91K	Sell	5,010 -4,510	-47%	-$58.7K	﹤0.01%	1189
2014 Q1	$142K	Sell	9,520 -480	-5%	-$8.62K	﹤0.01%	1158
2013 Q4	$183K	Buy	10,000 +1,400	+16%	+$28K	﹤0.01%	1055
2013 Q3	$177K	Buy	8,600 +710	+9%	+$16.3K	﹤0.01%	1069
2013 Q2	$198K	Buy	+7,890	New	+$337K	﹤0.01%	1051

Other funds holding AVEO

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Cornerstone Capital Management Holdings's AVEO Position: Q2 2015 in Review

Cornerstone Capital Management Holdings sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2015, closing a stake of 5,010 shares — an estimated $73K sold.

Cornerstone Capital Management Holdings first reported a position in AVEO in Q2 2013 and held it in 8 quarters. The position peaked at $198K in Q2 2013. 54 funds tracked by Wall St. Rank hold AVEO as of Q2 2015.

Cornerstone Capital Management Holdings reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 5,010 AVEO Pharmaceuticals, Inc. shares in Q2 2015, an estimated $73K.
Cornerstone Capital Management Holdings first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
Cornerstone Capital Management Holdings's AVEO Pharmaceuticals, Inc. position peaked at $198K in Q2 2013.
54 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2015, filed 11 Aug 2015.